May 17, 2021 Life Science Tools PR/Corporate

Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it is appointing Susan Tousi as Chief Commercial Officer (CCO), and Dr. Alex Aravanis as Chief Technology Officer (CTO), Head of Research and Product Development. “We’re fortunate to have Susan and Alex, two of the strongest leaders in the genomics industry, take on these large, important... Read more

May 17, 2021 Chromatography Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships Microscopy

PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC

Endocrinology testing specialist expands PerkinElmer’s immunodiagnostics segment WALTHAM, Mass.–(BUSINESS WIRE)–May 17, 2021– PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Immunodiagnostic Systems Holdings PLC (LSE: IHS) (“IDS”) are pleased to announce that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire IDS for approximately $155 million (£110 Million).... Read more

May 11, 2021 Licensing, IP, and Legal Life Science Tools

Court of Appeals for the Federal Circuit, US, upholds jury decision to invalidate certain PacBio patents

Tue 11th May 2021 Today the Court of Appeals for the Federal Circuit issued a unanimous Precedential Opinion and Judgment affirming the jury’s March 2020 verdict in the PacBio v. Oxford Nanopore case, that invalidated a number of PacBio patents.  This has been a long running dispute in which Oxford Nanopore has repeatedly prevailed.  In... Read more

May 5, 2021 Life Science Tools Product Launch

Oxford Nanopore provides updated kits and protocols for rapid, scalable and low-cost sequencing of SARS-CoV-2 genomes

Wed 5th May 2021 Oxford Nanopore has released new protocols enabling the rapid, cost effective sequencing of SARS-CoV-2 — the virus that causes COVID-19. Research teams are able to access sequencing technology in days, without capital cost, for quick set-up of rapid turnaround SARS-CoV-2 sequencing.  From initial characterisation of the SARS-CoV-2 virus genome to the rapid identification of variants, researchers have been... Read more

May 4, 2021 Bio/Pharma/CRO Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bio-Techne and 908 Devices Announce Joint Collaboration

MAY 04, 2021 MINNEAPOLIS and BOSTON, May 4, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) and 908 Devices (NASDAQ: MASS) today announced a joint collaboration to develop an extended workflow solution for protein characterization. Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and owner of the leading ProteinSimple... Read more

April 28, 2021 Life Science Tools

Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) has committed US $60 million in sequencing capabilities to a global pathogen genomics initiative, in partnership with the Bill & Melinda Gates Foundation and other public and private entities. The initiative expands on the Africa Pathogen Genomics Initiative (Africa PGI) announced in October 2020, and will help create a... Read more

April 27, 2021 Life Science Tools Product Launch

Bio-Techne Announces Commercial Release of Novel DNAscope In Situ Hybridization Assays for Chromogenic Detection of DNA Copy Number and Structural Variations

APRIL 27, 2021 Pushing the Spatial Genomics Frontier One Biomolecule at a Time from RNA to DNA MINNEAPOLIS, April 27, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope™ technology with release of new DNAscope Assays. The RNAscope technology is an advanced in situ hybridization (ISH)... Read more

April 26, 2021 Life Science Tools M&A, Partnerships

The Carlyle Group to acquire rapidly growing life sciences tools company Unchained Labs

April 26, 2021 – Pleasanton, CA – Global investment firm The Carlyle Group (NASDAQ:CG) today announced that it has agreed to acquire the rapidly growing life sciences tools company Unchained Labs for $435 million, in partnership with its management team, from Novo Holdings A/S, Canaan Partners and TPG Biotech. The transaction is subject to regulatory... Read more

April 26, 2021 Life Science Tools Liq. Handling & Robotics Product Launch

Pacific Biosciences Launches New HiFi Sequencing Workflow to Further Improve HiFi’s Industry Leading Accuracy

HiFi Sequencing and Software v10.1 Release on the Sequel II and IIe Systems Increases Scalability, Improves Usability, and Unlocks Additional Sample Types to Extend the Value of HiFi Reads MENLO PARK, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a global leader offering a comprehensive view of genomes, transcriptomes, and epigenomes,... Read more

April 26, 2021 Life Science Tools Liq. Handling & Robotics Product Launch

Pacific Biosciences Launches New HiFi Sequencing Workflow to Further Improve HiFi’s Industry Leading Accuracy

HiFi Sequencing and Software v10.1 Release on the Sequel II and IIe Systems Increases Scalability, Improves Usability, and Unlocks Additional Sample Types to Extend the Value of HiFi Reads MENLO PARK, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a global leader offering a comprehensive view of genomes, transcriptomes, and epigenomes,... Read more